Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01679184 · ClinicalTrials.gov registry record
XM-One Study for Living Donor Program
A clinical trial, sponsored by University of Miami.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01679184: Clinical Trial study, sponsored by University of Miami.
NCT01679184 is a clinical trial that was terminated before completion, run by University of Miami. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01679184 was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Donor-Specific Antibody (DSA) (HLA) levels and non-HLA antibody levels in recipients prior to living kidney transplantation and randomize these individuals into a desensitization protocol in order to evaluate shifts that can occur with the Luminex and XM-One assay after treatment and up to 6 months post transplant. If desensitization is needed prior to transplantation in individuals with a negative crossmatch but positive DSA and/or XM-one - patients will be evaluated clinically with routine lab tests (serum creatinine levels, spot urine protein and spot urine creatinine levels) as well as protocol biopsy evaluations.
Primary Outcome
To evaluate Donor-Specific Antibody (DSA) (HLA) levels with Luminex testing and non-HLA antibody levels using XM-One assay in recipients before and after transplantation for up to 6 months as well as in those recipients undergoing desensitization treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-09 |
Why NCT01679184 stopped before completion
NCT01679184 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01679184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01679184 about?
NCT01679184 is a clinical study titled "XM-One Study for Living Donor Program". Donor-Specific Antibody (DSA) (HLA) levels and non-HLA antibody levels in recipients prior to living kidney transplantation and randomize these individuals into a desensitization protocol in order to evaluate shifts that can occur with the Luminex and XM-One assay after treatment and up to 6 months ...
What is the current status of trial NCT01679184?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2013-06. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01679184?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia